Exploratory Analysis of Pruritus and Sleep Outcomes After LCR35 Supplementation in Maintenance Hemodialysis: A Randomized, Open-Label Controlled Study
Life · 05.08.2026 · 16 (8) · 1291
DOI: 10.3390/life16081291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 05.08.2026. Verfasst von Kuo-Chin Hung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, New Taipei City Hospital, New Taipei City 241204, Taiwan. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Uremic pruritus and sleep disturbance commonly coexist in patients receiving maintenance hemodialysis. This analysis examined whether supplementation with Lactobacillus casei var. rhamnosus LCR35 was associated with changes in pruritus and sleep outcomes.
Methods
This 12-week randomized, open-label, controlled study included 78 patients receiving maintenance hemodialysis who were assigned to LCR35 supplementation (n = 38; three sachets daily) or usual care without probiotic supplementation (n = 40). No placebo was used. Outcomes were Pittsburgh Sleep Quality Index (PSQI) and 5-D Itch Scale results. We used analysis of covariance (ANCOVA) for between-group analyses, with the week-12 score as the dependent variable and the corresponding baseline score as a covariate.
Results
In the LCR35 group, descriptive improvements were observed in the 5-D Itch Scale and selected PSQI outcomes. However, none of the baseline-adjusted between-group differences was statistically significant: for 5-D Itch Scale, −1.48 (95% confidence interval (CI), −3.64 to 0.68; p = 0.176); for global PSQI, −0.80 (95% CI, −2.09 to 0.50; p = 0.225); for PSQI sleep disturbance, −0.07 (95% CI, −0.27 to 0.13; p = 0.482); and use of sleep medications, −0.28 (95% CI, −0.67 to 0.12; p = 0.163). In the LCR35 group, the exploratory association between changes in pruritus and the PSQI sleep-disturbances component was significant before, but not after, false-discovery-rate (FDR) correction (p = 0.007; FDR q = 0.055).
Conclusions
Our preliminary findings raised the possibility that LCR35 might modestly influence pruritus and specific sleep disturbances. However, our results do not firmly establish a treatment effect, nor a patient phenotype most likely to benefit.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nephrology Department, New Taipei City Hospital, New Taipei City 241204, Taiwan.
- Department of Nursing, University of Kang Ning, Taipei 114311, Taiwan.
- Department of Pediatrics, Taoyuan Armed Forces General Hospital Hsinchu Branch, Hsinchu 30054, Taiwan.
- Department of Pediatrics, Tri-Service General Hospital, National Defense Medical University, Taipei 114201, Taiwan.
- Division of Nephrology, Department of Internal Medicine, Taipei Medical University-Shuang Ho Hospital, New Taipei City 235057, Taiwan.
- Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110052, Taiwan.
ORCID-Profile: Kuo-Chin Hung, Min-Tser Liao, Cai-Mei Zheng, Shih-Feng Chen, Li-Ting Lu, Chia-Ter Chao, Kuo-Cheng Lu
Zitieren
APA
Hung, K. C., Liao, M. T., Zheng, C. M., Chen, S. F., Lu, L. T., Chao, C. T., & Lu, K. C. (2026). Exploratory Analysis of Pruritus and Sleep Outcomes After LCR35 Supplementation in Maintenance Hemodialysis: A Randomized, Open-Label Controlled Study. Life, 16(8), 1291. https://doi.org/10.3390/life16081291
Vancouver
Hung KC, Liao MT, Zheng CM, Chen SF, Lu LT, Chao CT, et al. Exploratory Analysis of Pruritus and Sleep Outcomes After LCR35 Supplementation in Maintenance Hemodialysis: A Randomized, Open-Label Controlled Study. Life. 2026;16(8):1291. doi:10.3390/life16081291
BibTeX
@article{Hung2026,
author = {Hung, Kuo-Chin and Liao, Min-Tser and Zheng, Cai-Mei and Chen, Shih-Feng and Lu, Li-Ting and Chao, Chia-Ter and Lu, Kuo-Cheng},
title = {Exploratory Analysis of Pruritus and Sleep Outcomes After LCR35 Supplementation in Maintenance Hemodialysis: A Randomized, Open-Label Controlled Study},
journal = {Life},
year = {2026},
volume = {16},
number = {8},
pages = {1291},
doi = {10.3390/life16081291}
}
EUVIMED